Federal Register / Vol. 66, No. 106 / Friday, June 1, 2001 / Notices 29811

3The units shipped total is based on combined

actual or estimated industry figures for calendar

year 2000 across all of the product categories,

except for fluorescent lamp ballasts, lamp products,

and plumbing fixtures. Staff has determined that,

for those product categories, there are little or no

costs associated with the labeling requirements. The

fact sheet estimation is based on the previously

noted assumption that five percent of HVAC

manufacturers produce fact sheets on their own.

Based on total HVAC units shipped (10,291,965),

five percent amounts to 514,598 HVAC units.

Because manufacturers generally list more than one

unit on a fact sheet, staff has estimated that

manufacturers independently preparing them will

use one sheet for every four of these 514,598 units.

Thus, staff estimates that HVAC manufacturers

produce approximately 128,650 fact sheets.

Activity Burden hours

per year Wage category hourly rate Total annuallabor cost

Recordkeeping .............................................................. 934 Clerical/$10 ................................................................... 9,340

Labeling, marking, and fact sheet preparation ............. 101,333 Clerical/$10 ................................................................... 1,013,330

Catalog disclosures ...................................................... 2,550 Clerical/$10 ................................................................... 25,500

7,827,250

Capital or Other Non-Labor Costs:

$3,519,000 (rounded), determined as

follows:

Staff has examined the five distinct

burdens imposed by EPCA through the

Rule–testing, reporting, recordkeeping,

labeling, and retail catalog disclosures—

as they affect the 11 groups of products

that the rule covers. Staff has concluded

that there are no current start-up costs

associated with the rule. Manufacturers

have in place the capital equipment

necessary—especially equipment to

measure energy and/or water usage—to

comply with the rule.

Under this analysis, testing,

recordkeeping, and retail catalog

disclosures are activities that incur no

capital or other non-labor costs. As

mentioned above, testing has been

performed in these industries in the

normal course of business for many

years as has the associated

recordkeeping. The same is so for

regarding compliance applicable to the

requirements for paper catalogs.

Manufacturers and retailers who make

required disclosures in catalogs already

are producing catalogs in the ordinary

course of their businesses; accordingly,

capital cost associated with such

disclosure would be minimal or nil.

Staff recognizes that there may be initial

costs associated with posting online

disclosure, and it invites further

comment to reasonably quantify such

costs.

Manufacturers that submit required

reports to the Commission directly

(rather than through trade associations)

incur some nominal costs for paper and

postage. Staff estimates that these costs

do not exceed $2,500. Manufacturers

must also incur the cost of procuring

labels and fact sheets used in

compliance with the rule. Based on

estimates of 50,113,098 units shipped

and 128,650 fact sheets prepared,3 at an

average cost of seven cents for each

label or fact sheet, the total (rounded—

labeling cost is $3,516.922.

John D. Grubert,

Acting General Counsel.

[FR Doc. 01–13707 Filed 5–31–01; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Request for Nominations of Members

to the Advisory Committee on Blood

Safety and Availability

AGENCY: Office of the Secretary, HHS.

ACTION: Announcement of request for

membership nominations.

SUMMARY: The Office of the Secretary

requests nomination of individuals to

serve on the Advisory Committee on

Blood Safety and Availability in

accordance with its charter.

Appointments will be made for a term

of four years. Individuals nominated

after June 1, 2000 will remain under

consideration for these appointments.

DATES: All nominations must be

received at the address below no later

than 4 p.m. EDT August 31, 2001.

ADDRESSES: All nominations shall be

submitted to Stephen D. Nightingale,

M.D., Executive Secretary, Advisory

Committee on Blood Safety and

Availability, Office of Public Health and

Science, Department of Health and

Human Services, 200 Independence

Ave., SW., Washington, DC 20201.

Phone (202) 690–5560.

FOR FURTHER INFORMATION CONTACT:

Stephen D. Nightingale, M.D., Executive

Secretary, Advisory Committee on

Blood Safety and Availability, Office of

Public Health and Science, Department

of Health and Human Services, Room

736–E, 200 Independence Ave., SW.,

Washington, DC 20201. Phone (202)

690–5560.

Nominations: In accordance with the

charter of the Committee, persons

nominated for membership should be

from among authorities knowledgeable

in blood banking, transfusion medicine,

bioethics and/or related disciplines.

Members shall be selected from State

and local organizations, blood and

blood products industry including

manufacturers and distributors,

advocacy groups, consumer advocates,

provider organizations, academic

researchers, ethicists, private

physicians, scientists, consumer

advocates, legal organizations and from

among communities of persons who are

frequent recipients of blood and blood

products.

Information Required: Each

nomination shall consist of a package

that, at a minimum, includes:

A. The name, return address, daytime

telephone number and affiliation(s) of

the individual being nominated, the

basis for the individual’s nomination,

the category for which the individual is

nominated, and a statement bearing an

original signature of the nominated

individual that he or she is willing to

serve as a member of the committee;

B. The name, return address, daytime

telephone number at which the

nominator may be contacted.

Organizational nominators must

identify a principal contact person in

addition to the contact person in

addition to the contact information; and

C. A copy of the nominee’s

curriculum vitae.

The Department of Health and Human

Services has a strong interest in

ensuring that women, minority groups,

and physically challenged individuals

are adequately represented on the

Committee and, therefore, encourages

nomination of qualified candidates from

these groups. The Department also

encourages geographic diversity in the

composition of the Committee.

Individuals should feel free to

nominate themselves. All nomination

information for a nominee must be

provided in a complete single package.

Incomplete nominations will not be

processed. Nomination materials must

bear original signatures, and facsimile

transmission or copies are not

acceptable.

29812 Federal Register / Vol. 66, No. 106 / Friday, June 1, 2001 / Notices

Dated: May 21, 2001.

Stephen D. Nightingale,

Executive Secretary, Advisory Committee on

Blood Safety and Availability.

[FR Doc. 01–13745 Filed 5–31–01; 8:45 am]

BILLING CODE 4150–28–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of Public Health and Science

Announcement of Availability of Funds

for Research in Family Planning

Service Delivery Improvement

AGENCY: Office of Population Affairs,

OPHS, DHHS.

ACTION: Notice.

SUMMARY: The Office of Population

Affairs (OPA) requests applications for

family planning service delivery

improvement research grants.

Applications should address Title X

Family Planning Program priorities in

two general areas: (1) Providing family

planning and reproductive health

services to undeserved populations; and

(2) assessing the impact of increasing

costs on the delivery of family planning

and reproductive health services.

DATES: The closing date for this grant

announcement is July 26, 2001.

Applications will be considered as

meeting the deadline date if they are: (1)

Received on or before the deadline date

or (2) postmarked on or before the

deadline date and received in time to be

considered during the competitive

review process. A legible date receipt

from a commercial carrier or U.S. Postal

Service will be accepted in lieu of a

postmark. Private metered postmarks

will not be accepted as proof of timely

mailing. Applications which do not

conform to requirements of this

announcement will be accepted for

review. Applicants will be so notified

and the applications will be returned.

ADDRESSES: Application kits may be

obtained from the Office of Population

Affairs, Office of Grants Management,

4350 East-West Highway, Suite 200,

Bethesda, MD 20814. Application kits

may also be downloaded from the OPA

web site at http://www.hhs.gov/opa or

requests may be faxed to (301) 594–

5980. To facilitate the handling of

written requests, please include: name,

title, organization, mailing address,

telephone number and e-mail address.

All completed applications must be

submitted to the Office of Grants

Management at the above mailing

address. Please label the application

envelope: ‘‘Attention: Family Planning

Research.’’

FOR FURTHER INFORMATION CONTACT: For

information on specific research issues:

Eugenia Eckard, Office of Population

Affairs, (301) 594–6534. For questions

about the technical preparation of the

grant application: Andrea Brandon,

Grants Management Officer, (301) 594–

4012.

SUPPLEMENTARY INFORMATION: Title X of

the Public Health Service Act (42 U.S.C.

300a–2) authorizes the Secretary of

Health and Human Services to award

grants and enter into contracts with

public agencies or private nonprofit

entities to provide research in

behavioral and program implementation

fields related to family planning.

(Catalogue of Federal Domestic

Assistance No. 93.974.) This research

program is not subject to the

intergovernmental review requirements

of Executive Order 12372 and 45 CFR

100.

It is the policy of OPA that women

and members of minority groups and

their subpopulations be included in all

OPA supported research projects

involving human subjects, unless a clear

and compelling rationale and

justification are provided indicating that

inclusion is inappropriate with respect

to the health of the subject or the

purpose of the research.

All investigators proposing research

involving human subject should read

the updated ‘‘NIH Guidelines for

Inclusion of Women and Minorities as

Subjects in Clinical Research’’,

published in the NIH Guide for Grants

and Contracts on August 2, 2000 and

available at: http://grants.nih.gov/

grants/funding/women_min/

guidelines_update.htm.

In the interest of making data

available to others, copies of data sets

and accompanying documentation

produced with funds granted trough this

announcement will be deposited with a

public use data achieve or with the

OPA. The cost of making such data

available should be budgeted in the

proposal.

Applications should address how

findings from the proposed study will

have general applicability to the

improvement of the delivery of family

planning services, and a plan must be

presented on how information from the

research findings will be disseminated.

Healthy People 2010: The OPA is

committed to achieving the health

promotion and disease prevention

objectives of ‘‘Healthy People 2010,’’ a

PHS-led national activity for setting

priority areas. This Request for

Applications (RFA) is related to one or

more of the priority areas, in particular

the focus area on family planning.

Potential applicants may obtain

‘‘Healthy People 2010’’ at http://

www.health.gov/healthypeople.

Research Goals and Scope: The

primary purpose of the Title X Family

Planning Program is to provide family

planning and reproductive health

services to all persons desiring them. To

that end, the program is guided by a set

of priorities: maintain a high level of

quality in the family planning and

reproductive health services delivered;

ensure comprehensiveness in the range

of services offered, and; increase access

to services through partnerships with

other public health providers and

community-based organizations, as well

as outreach to underserved populations.

This RFA invites proposals for applied

research to address these priorities in

two general areas: (1) Providing family

planning and reproductive health

services to underserved populations;

and (2) assessing the impact of

increasing costs on the delivery of

family planning and reproductive health

services.

Underserved Populations

It has been demonstrated that access

to family planning and reproductive

health services has a positive impact on

reducing the incidence of sexually

transmitted diseases (STD)/HIV

infection, unintended pregnancy,

abortion, maternal and infant morbidity

and mortality, and diseases of the

reproductive system. The Title X Family

Planning Program was established in

1970 to facilitate such access by offering

a broad range and family planning and

reproductive health services-at low or

no cost, on a voluntary and confidential

basis, and without regard to race,

national origin, age, gender, or

disability.

The Title X program currently serves

approximately 4.5 million persons

annually and service data indicate the

program is meeting its mandate of

providing family planning and

reproductive health services to many of

those in need. For example, a major

barrier to receiving health care is its

cost. Title X regulations specify that

priority in the provision of services be

given to persons from low income

families and, in 1999, 83 percent of Title

X clients had family incomes at or

below 150 percent of the poverty level.

There are, however, factors other than

low income that can have a negative

impact on the ability of come

populations to obtain family planning

and reproductive health services. Of

particular concern are the social,

cultural, physical, and language barriers

that may hinder access for certain

populations subgroups. These factors